FDA Inspection 1304742 — BioLife Plasma Services LP
The FDA completed an inspection of BioLife Plasma Services LP on February 23, 2026 in Mesquite, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 23, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mesquite, TX (United States)